There is no current evidence that obstructive sleep apnoea (OSA) increases the risk for getting or developing complications of coronavirus (COVID-19). However, many patients with OSA may also have other long term health problems that may increase their risk. Please ensure that if you are affected by any other conditions that you check if they are relevant for COVID-19.
Continuous positive airway pressure (CPAP)
CPAP therapy improves long-term cardiovascular outcomes in patients with OSA as well as improving sleep quality and daytime alertness. Continued CPAP therapy would be recommended if you have no symptoms of COVID-19. In the event you develop symptoms there is the potential for CPAP to increase the risk of spread to other people in the area of the CPAP device (ie your close household contacts).
Short periods off CPAP therapy are unlikely to significantly affect your long-term health if you have previously done the therapy as directed. There may be an increase in daytime sleepiness. We advise against taking part in any potentially dangerous tasks, such as driving if your symptoms return when stopping CPAP.